Catalyzing Growth: Venture Capital Insights for Alberta's Emerging Life Sciences Sector

Join us for an insightful discussion on the burgeoning life sciences sector in Alberta, presented from the unique perspective of an early-stage venture capital investor based in Alberta. Investment Manager Arden Tse will share what he sees as some critical challenges faced by nascent life sciences companies in Alberta, particularly in securing early-stage funding and commercializing research innovations. As the sector experiences growth, there remains a significant gap in both funding and commercial expertise. Arden is committed to helping bridge these gaps, cultivating and supporting entrepreneurs and researchers while educating other investors on the opportunities in this sector. Attendees will gain valuable insights into the intricacies of venture capital investment in the life sciences, and how Yaletown plans to help empower the next wave of innovators in Alberta. This session is aimed at researchers and entrepreneurs eager to understand and navigate the evolving landscape of early-stage life sciences venture capital in Alberta.

About Accelerate Fund:

Accelerate Fund III is an early-stage venture capital fund managed by Yaletown Partners. Yaletown is one of Canada's longest standing Venture Capital firms with offices in Vancouver, Edmonton, Calgary, Montreal, Toronto, and San Francisco. The Accelerate Fund helps to foster the growth of Alberta’s technology sector and diversify the province’s economy by investing in early-stage startups and preparing them for further venture capital investment as they grow. Capital for Accelerate Fund comes from Alberta Enterprise Corporation, an organization that works on behalf of the Government of Alberta to invest in venture capital funds to support the growth of early-stage technology companies, and it is managed in partnership between Yaletown and the A100 with a dedicated team based in Alberta.

You can learn more and register for this event right here.